The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brucella Abortus Vaccine Market Research Report 2025
Synopsis
The global Brucella Abortus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brucella Abortus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Abortus Vaccine.
Report Scope
The Brucella Abortus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brucella Abortus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brucella Abortus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health
Segment by Type
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others
Segment by Application
Cattles
Sheep
Pigs
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brucella Abortus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Brucella Abortus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brucella Abortus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Abortus Vaccine.
Report Scope
The Brucella Abortus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brucella Abortus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brucella Abortus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health
Segment by Type
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others
Segment by Application
Cattles
Sheep
Pigs
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brucella Abortus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Brucella Abortus Vaccine Market Overview
1.1 Product Overview and Scope of Brucella Abortus Vaccine
1.2 Brucella Abortus Vaccine Segment by Type
1.2.1 Global Brucella Abortus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 DNA Vaccines
1.2.3 Subunit Vaccines
1.2.4 Vector Vaccines
1.2.5 B. Abortus Recombinant Mutants
1.2.6 Others
1.3 Brucella Abortus Vaccine Segment by Application
1.3.1 Global Brucella Abortus Vaccine Market Value by Application: (2024-2030)
1.3.2 Cattles
1.3.3 Sheep
1.3.4 Pigs
1.3.5 Others
1.4 Global Brucella Abortus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Brucella Abortus Vaccine Revenue 2019-2030
1.4.2 Global Brucella Abortus Vaccine Sales 2019-2030
1.4.3 Global Brucella Abortus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Brucella Abortus Vaccine Market Competition by Manufacturers
2.1 Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Brucella Abortus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Brucella Abortus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Brucella Abortus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brucella Abortus Vaccine, Product Type & Application
2.7 Brucella Abortus Vaccine Market Competitive Situation and Trends
2.7.1 Brucella Abortus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Brucella Abortus Vaccine Players Market Share by Revenue
2.7.3 Global Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Brucella Abortus Vaccine Retrospective Market Scenario by Region
3.1 Global Brucella Abortus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Brucella Abortus Vaccine Global Brucella Abortus Vaccine Sales by Region: 2019-2030
3.2.1 Global Brucella Abortus Vaccine Sales by Region: 2019-2024
3.2.2 Global Brucella Abortus Vaccine Sales by Region: 2025-2030
3.3 Global Brucella Abortus Vaccine Global Brucella Abortus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Brucella Abortus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Brucella Abortus Vaccine Revenue by Region: 2025-2030
3.4 North America Brucella Abortus Vaccine Market Facts & Figures by Country
3.4.1 North America Brucella Abortus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Brucella Abortus Vaccine Sales by Country (2019-2030)
3.4.3 North America Brucella Abortus Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Brucella Abortus Vaccine Market Facts & Figures by Country
3.5.1 Europe Brucella Abortus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Brucella Abortus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Brucella Abortus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Brucella Abortus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Brucella Abortus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Brucella Abortus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Brucella Abortus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Brucella Abortus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Brucella Abortus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Brucella Abortus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Brucella Abortus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Brucella Abortus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brucella Abortus Vaccine Sales by Type (2019-2030)
4.1.1 Global Brucella Abortus Vaccine Sales by Type (2019-2024)
4.1.2 Global Brucella Abortus Vaccine Sales by Type (2025-2030)
4.1.3 Global Brucella Abortus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Brucella Abortus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Brucella Abortus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Brucella Abortus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Brucella Abortus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Brucella Abortus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Brucella Abortus Vaccine Sales by Application (2019-2030)
5.1.1 Global Brucella Abortus Vaccine Sales by Application (2019-2024)
5.1.2 Global Brucella Abortus Vaccine Sales by Application (2025-2030)
5.1.3 Global Brucella Abortus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Brucella Abortus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Brucella Abortus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Brucella Abortus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Brucella Abortus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Brucella Abortus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Corporation Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CEVA Brucella Abortus Vaccine Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Biovet
6.4.1 Biovet Corporation Information
6.4.2 Biovet Description and Business Overview
6.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biovet Brucella Abortus Vaccine Product Portfolio
6.4.5 Biovet Recent Developments/Updates
6.5 CAVAC
6.5.1 CAVAC Corporation Information
6.5.2 CAVAC Description and Business Overview
6.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CAVAC Brucella Abortus Vaccine Product Portfolio
6.5.5 CAVAC Recent Developments/Updates
6.6 JOVAC
6.6.1 JOVAC Corporation Information
6.6.2 JOVAC Description and Business Overview
6.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JOVAC Brucella Abortus Vaccine Product Portfolio
6.6.5 JOVAC Recent Developments/Updates
6.7 Merial
6.6.1 Merial Corporation Information
6.6.2 Merial Description and Business Overview
6.6.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merial Brucella Abortus Vaccine Product Portfolio
6.7.5 Merial Recent Developments/Updates
6.8 Colorado Serum Company
6.8.1 Colorado Serum Company Corporation Information
6.8.2 Colorado Serum Company Description and Business Overview
6.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
6.8.5 Colorado Serum Company Recent Developments/Updates
6.9 VECOL
6.9.1 VECOL Corporation Information
6.9.2 VECOL Description and Business Overview
6.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 VECOL Brucella Abortus Vaccine Product Portfolio
6.9.5 VECOL Recent Developments/Updates
6.10 Tecnovax
6.10.1 Tecnovax Corporation Information
6.10.2 Tecnovax Description and Business Overview
6.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
6.10.5 Tecnovax Recent Developments/Updates
6.11 Indian Immunologicals
6.11.1 Indian Immunologicals Corporation Information
6.11.2 Indian Immunologicals Brucella Abortus Vaccine Description and Business Overview
6.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
6.11.5 Indian Immunologicals Recent Developments/Updates
6.12 Vetal
6.12.1 Vetal Corporation Information
6.12.2 Vetal Brucella Abortus Vaccine Description and Business Overview
6.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vetal Brucella Abortus Vaccine Product Portfolio
6.12.5 Vetal Recent Developments/Updates
6.13 Dollvet
6.13.1 Dollvet Corporation Information
6.13.2 Dollvet Brucella Abortus Vaccine Description and Business Overview
6.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dollvet Brucella Abortus Vaccine Product Portfolio
6.13.5 Dollvet Recent Developments/Updates
6.14 Centro Diagnostico Veterinario
6.14.1 Centro Diagnostico Veterinario Corporation Information
6.14.2 Centro Diagnostico Veterinario Brucella Abortus Vaccine Description and Business Overview
6.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
6.14.5 Centro Diagnostico Veterinario Recent Developments/Updates
6.15 Onderstepoort Biological Products
6.15.1 Onderstepoort Biological Products Corporation Information
6.15.2 Onderstepoort Biological Products Brucella Abortus Vaccine Description and Business Overview
6.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
6.15.5 Onderstepoort Biological Products Recent Developments/Updates
6.16 Institute of Animal Health and Veterinary Biologicals
6.16.1 Institute of Animal Health and Veterinary Biologicals Corporation Information
6.16.2 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Description and Business Overview
6.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
6.16.5 Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
6.17 Biogenesis Bago
6.17.1 Biogenesis Bago Corporation Information
6.17.2 Biogenesis Bago Brucella Abortus Vaccine Description and Business Overview
6.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
6.17.5 Biogenesis Bago Recent Developments/Updates
6.18 Instituto Rosenbusch
6.18.1 Instituto Rosenbusch Corporation Information
6.18.2 Instituto Rosenbusch Brucella Abortus Vaccine Description and Business Overview
6.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
6.18.5 Instituto Rosenbusch Recent Developments/Updates
6.19 SYVA Laboratorios
6.19.1 SYVA Laboratorios Corporation Information
6.19.2 SYVA Laboratorios Brucella Abortus Vaccine Description and Business Overview
6.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
6.19.5 SYVA Laboratorios Recent Developments/Updates
6.20 CZ Veterinaria
6.20.1 CZ Veterinaria Corporation Information
6.20.2 CZ Veterinaria Brucella Abortus Vaccine Description and Business Overview
6.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
6.20.5 CZ Veterinaria Recent Developments/Updates
6.21 Hester Biosciences
6.21.1 Hester Biosciences Corporation Information
6.21.2 Hester Biosciences Brucella Abortus Vaccine Description and Business Overview
6.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
6.21.5 Hester Biosciences Recent Developments/Updates
6.22 Qilu Animal Health
6.22.1 Qilu Animal Health Corporation Information
6.22.2 Qilu Animal Health Brucella Abortus Vaccine Description and Business Overview
6.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
6.22.5 Qilu Animal Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brucella Abortus Vaccine Industry Chain Analysis
7.2 Brucella Abortus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brucella Abortus Vaccine Production Mode & Process
7.4 Brucella Abortus Vaccine Sales and Marketing
7.4.1 Brucella Abortus Vaccine Sales Channels
7.4.2 Brucella Abortus Vaccine Distributors
7.5 Brucella Abortus Vaccine Customers
8 Brucella Abortus Vaccine Market Dynamics
8.1 Brucella Abortus Vaccine Industry Trends
8.2 Brucella Abortus Vaccine Market Drivers
8.3 Brucella Abortus Vaccine Market Challenges
8.4 Brucella Abortus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Brucella Abortus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Brucella Abortus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Brucella Abortus Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Brucella Abortus Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Brucella Abortus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Brucella Abortus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Brucella Abortus Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Brucella Abortus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Brucella Abortus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Brucella Abortus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Brucella Abortus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Brucella Abortus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Brucella Abortus Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Brucella Abortus Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Brucella Abortus Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Brucella Abortus Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Brucella Abortus Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Brucella Abortus Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Brucella Abortus Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Brucella Abortus Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Brucella Abortus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Brucella Abortus Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Brucella Abortus Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Brucella Abortus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Brucella Abortus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Brucella Abortus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Brucella Abortus Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Brucella Abortus Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Brucella Abortus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Brucella Abortus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Brucella Abortus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Brucella Abortus Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Brucella Abortus Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Brucella Abortus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Brucella Abortus Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Brucella Abortus Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Brucella Abortus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Brucella Abortus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Brucella Abortus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Brucella Abortus Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Brucella Abortus Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Brucella Abortus Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Brucella Abortus Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Brucella Abortus Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Brucella Abortus Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Brucella Abortus Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Brucella Abortus Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Brucella Abortus Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Brucella Abortus Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Brucella Abortus Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Brucella Abortus Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Brucella Abortus Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Brucella Abortus Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Brucella Abortus Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Brucella Abortus Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Brucella Abortus Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Brucella Abortus Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Brucella Abortus Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Brucella Abortus Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Brucella Abortus Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Brucella Abortus Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Zoetis Brucella Abortus Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. CEVA Corporation Information
Table 76. CEVA Description and Business Overview
Table 77. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CEVA Brucella Abortus Vaccine Product
Table 79. CEVA Recent Developments/Updates
Table 80. Merck Animal Health Corporation Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Animal Health Brucella Abortus Vaccine Product
Table 84. Merck Animal Health Recent Developments/Updates
Table 85. Biovet Corporation Information
Table 86. Biovet Description and Business Overview
Table 87. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Biovet Brucella Abortus Vaccine Product
Table 89. Biovet Recent Developments/Updates
Table 90. CAVAC Corporation Information
Table 91. CAVAC Description and Business Overview
Table 92. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. CAVAC Brucella Abortus Vaccine Product
Table 94. CAVAC Recent Developments/Updates
Table 95. JOVAC Corporation Information
Table 96. JOVAC Description and Business Overview
Table 97. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. JOVAC Brucella Abortus Vaccine Product
Table 99. JOVAC Recent Developments/Updates
Table 100. Merial Corporation Information
Table 101. Merial Description and Business Overview
Table 102. Merial Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Merial Brucella Abortus Vaccine Product
Table 104. Merial Recent Developments/Updates
Table 105. Colorado Serum Company Corporation Information
Table 106. Colorado Serum Company Description and Business Overview
Table 107. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Colorado Serum Company Brucella Abortus Vaccine Product
Table 109. Colorado Serum Company Recent Developments/Updates
Table 110. VECOL Corporation Information
Table 111. VECOL Description and Business Overview
Table 112. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. VECOL Brucella Abortus Vaccine Product
Table 114. VECOL Recent Developments/Updates
Table 115. Tecnovax Corporation Information
Table 116. Tecnovax Description and Business Overview
Table 117. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Tecnovax Brucella Abortus Vaccine Product
Table 119. Tecnovax Recent Developments/Updates
Table 120. Indian Immunologicals Corporation Information
Table 121. Indian Immunologicals Description and Business Overview
Table 122. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Indian Immunologicals Brucella Abortus Vaccine Product
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Vetal Corporation Information
Table 126. Vetal Description and Business Overview
Table 127. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Vetal Brucella Abortus Vaccine Product
Table 129. Vetal Recent Developments/Updates
Table 130. Dollvet Corporation Information
Table 131. Dollvet Description and Business Overview
Table 132. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Dollvet Brucella Abortus Vaccine Product
Table 134. Dollvet Recent Developments/Updates
Table 135. Centro Diagnostico Veterinario Corporation Information
Table 136. Centro Diagnostico Veterinario Description and Business Overview
Table 137. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product
Table 139. Centro Diagnostico Veterinario Recent Developments/Updates
Table 140. Onderstepoort Biological Products Corporation Information
Table 141. Onderstepoort Biological Products Description and Business Overview
Table 142. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Onderstepoort Biological Products Brucella Abortus Vaccine Product
Table 144. Onderstepoort Biological Products Recent Developments/Updates
Table 145. Institute of Animal Health and Veterinary Biologicals Corporation Information
Table 146. Institute of Animal Health and Veterinary Biologicals Description and Business Overview
Table 147. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product
Table 149. Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
Table 150. Biogenesis Bago Corporation Information
Table 151. Biogenesis Bago Description and Business Overview
Table 152. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Biogenesis Bago Brucella Abortus Vaccine Product
Table 154. Biogenesis Bago Recent Developments/Updates
Table 155. Instituto Rosenbusch Corporation Information
Table 156. Instituto Rosenbusch Description and Business Overview
Table 157. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Instituto Rosenbusch Brucella Abortus Vaccine Product
Table 159. Instituto Rosenbusch Recent Developments/Updates
Table 160. SYVA Laboratorios Corporation Information
Table 161. SYVA Laboratorios Description and Business Overview
Table 162. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. SYVA Laboratorios Brucella Abortus Vaccine Product
Table 164. SYVA Laboratorios Recent Developments/Updates
Table 165. CZ Veterinaria Corporation Information
Table 166. CZ Veterinaria Description and Business Overview
Table 167. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. CZ Veterinaria Brucella Abortus Vaccine Product
Table 169. CZ Veterinaria Recent Developments/Updates
Table 170. Hester Biosciences Corporation Information
Table 171. Hester Biosciences Description and Business Overview
Table 172. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Hester Biosciences Brucella Abortus Vaccine Product
Table 174. Hester Biosciences Recent Developments/Updates
Table 175. Qilu Animal Health Corporation Information
Table 176. Qilu Animal Health Description and Business Overview
Table 177. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Qilu Animal Health Brucella Abortus Vaccine Product
Table 179. Qilu Animal Health Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Brucella Abortus Vaccine Distributors List
Table 183. Brucella Abortus Vaccine Customers List
Table 184. Brucella Abortus Vaccine Market Trends
Table 185. Brucella Abortus Vaccine Market Drivers
Table 186. Brucella Abortus Vaccine Market Challenges
Table 187. Brucella Abortus Vaccine Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Brucella Abortus Vaccine
Figure 2. Global Brucella Abortus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Brucella Abortus Vaccine Market Share by Type in 2023 & 2030
Figure 4. DNA Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Vector Vaccines Product Picture
Figure 7. B. Abortus Recombinant Mutants Product Picture
Figure 8. Others Product Picture
Figure 9. Global Brucella Abortus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Brucella Abortus Vaccine Market Share by Application in 2023 & 2030
Figure 11. Cattles
Figure 12. Sheep
Figure 13. Pigs
Figure 14. Others
Figure 15. Global Brucella Abortus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Brucella Abortus Vaccine Market Size (2019-2030) & (US$ Million)
Figure 17. Global Brucella Abortus Vaccine Sales (2019-2030) & (K Units)
Figure 18. Global Brucella Abortus Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 19. Brucella Abortus Vaccine Report Years Considered
Figure 20. Brucella Abortus Vaccine Sales Share by Manufacturers in 2023
Figure 21. Global Brucella Abortus Vaccine Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Brucella Abortus Vaccine Players: Market Share by Revenue in 2023
Figure 23. Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Brucella Abortus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Brucella Abortus Vaccine Sales Market Share by Country (2019-2030)
Figure 26. North America Brucella Abortus Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Brucella Abortus Vaccine Sales Market Share by Country (2019-2030)
Figure 30. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2019-2030)
Figure 31. Germany Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Region (2019-2030)
Figure 38. China Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Brucella Abortus Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Latin America Brucella Abortus Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Brucella Abortus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Brucella Abortus Vaccine by Type (2019-2030)
Figure 59. Global Revenue Market Share of Brucella Abortus Vaccine by Type (2019-2030)
Figure 60. Global Brucella Abortus Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Brucella Abortus Vaccine by Application (2019-2030)
Figure 62. Global Revenue Market Share of Brucella Abortus Vaccine by Application (2019-2030)
Figure 63. Global Brucella Abortus Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 64. Brucella Abortus Vaccine Value Chain
Figure 65. Brucella Abortus Vaccine Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
